Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pyrimethamine with sulfadoxine |
Is a |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by pyrimethamine (disorder) |
Causative agent (attribute) |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental pyrimethamine poisoning |
Causative agent (attribute) |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional pyrimethamine poisoning (disorder) |
Causative agent (attribute) |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la pyriméthamine d'intention indéterminée |
Causative agent (attribute) |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrimethamine adverse reaction |
Causative agent (attribute) |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrimethamine allergy |
Causative agent (attribute) |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyrimethamine overdose |
Causative agent (attribute) |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental pyrimethamine overdose |
Causative agent (attribute) |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional pyrimethamine overdose |
Causative agent (attribute) |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de pyriméthamine d'intention indéterminée |
Causative agent (attribute) |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyrimethamine 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyrimethamine + sulfadoxine 25mg/500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyrimethamine (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dapsone- and pyrimethamine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing pyrimethamine and sulfadoxine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental pyrimethamine poisoning |
Causative agent (attribute) |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional pyrimethamine poisoning (disorder) |
Causative agent (attribute) |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrimethamine allergy |
Causative agent (attribute) |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrimethamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrimethamine- and sulfadoxine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Pyrimethamine 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrimethamine 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dapsone- and pyrimethamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrimethamine 25 mg oral tablet |
Has precise active ingredient |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet |
Has precise active ingredient |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only dapsone and pyrimethamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only pyrimethamine and sulfadoxine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only pyrimethamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrimethamine and sulfadoxine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only pyrimethamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dapsone and pyrimethamine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyrimethamine 12.5 milligram and sulfadoxine 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyrimethamine 12.5 milligram and sulfadoxine 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pyrimethamine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |